Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the United States and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products, and other products. Its Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Its Diversified segment consists of sales in the United States of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Its Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, surgical and pharmaceutical products.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļBHC
āļāļ·āđāļāļāļĢāļīāļĐāļąāļBausch Health Companies Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļSep 20, 1994
āļāļĩāļāļĩāđāļMr. Thomas J. Appio
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ20700
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļSep 20
āļāļĩāđāļāļĒāļđāđ2150 St. Elzear Blvd. West
āđāļĄāļ·āļāļLAVAL
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđThe Toronto Stock Exchange
āļāļĢāļ°āđāļāļĻCanada
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđH7L 4A8
āđāļāļĢāļĻāļąāļāļāđ18003611448
āđāļ§āđāļāđāļāļāđhttps://www.bauschhealth.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļBHC
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļSep 20, 1994
āļāļĩāļāļĩāđāļMr. Thomas J. Appio
Mr. Thomas J. Appio
Chief Executive Officer, Director
Chief Executive Officer, Director
Dr. Amy B. Wechsler, M.D.
Dr. Amy B. Wechsler, M.D.
Independent Director
Mr. Robert N. Power
Independent Director
Mr. Steven D. Miller
Independent Director
Mr. Brett M. Icahn
Independent Director
Mr. Michael Goettler
Director
Ms. Aimee J. Lenar
Executive Vice President, US Pharma
Executive Vice President, US Pharma
Dr. Richard C. Mulligan, Ph.D.
Dr. Richard C. Mulligan, Ph.D.
Independent Director
Mr. John A. Paulson
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Thomas J. Appio
Chief Executive Officer, Director
Chief Executive Officer, Director
Dr. Amy B. Wechsler, M.D.
Dr. Amy B. Wechsler, M.D.
Independent Director
Mr. Robert N. Power
Independent Director
Mr. Steven D. Miller
Independent Director
Mr. Brett M. Icahn
Independent Director
VanEck Pharmaceutical ETF
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index ETF
JPMorgan International Value ETF
Schwab International Small-Cap Equity ETF
iShares Intl Small Cap Equity Factor ETF
DFA Dimensional International Small Cap ETF
Schwab Fundamental International Equity ETF
Invesco RAFI Developed Mkts ex-US ETF
DFA Dimensional Intl Sustainability Core 1 ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Gotham 1000 Value ETF
āļŠāļąāļāļŠāđāļ§āļ0.18%
VanEck Pharmaceutical ETF
āļŠāļąāļāļŠāđāļ§āļ0.14%
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index ETF
āļŠāļąāļāļŠāđāļ§āļ0.12%
JPMorgan International Value ETF
āļŠāļąāļāļŠāđāļ§āļ0.09%
Schwab International Small-Cap Equity ETF
āļŠāļąāļāļŠāđāļ§āļ0.08%
iShares Intl Small Cap Equity Factor ETF
āļŠāļąāļāļŠāđāļ§āļ0.06%
DFA Dimensional International Small Cap ETF
āļŠāļąāļāļŠāđāļ§āļ0.05%
Schwab Fundamental International Equity ETF
āļŠāļąāļāļŠāđāļ§āļ0.04%
Invesco RAFI Developed Mkts ex-US ETF
āļŠāļąāļāļŠāđāļ§āļ0.03%
DFA Dimensional Intl Sustainability Core 1 ETF
āļŠāļąāļāļŠāđāļ§āļ0.01%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ